|
Session 132-Poster Abstracts
Hepatitis: Cirrhosis, Cancer, and Transplant
Thursday, 2-4 pm; Poster Hall |
| 684 |
Survival of HIV-infected Patients with Compensated Liver Cirrhosis Paula Tuma*1, I Jarrin2, J del Amo2, E Vispo1, J Medrano1, L Martin-Carbonero1, P Labarga1, P Barreiro1, and V Soriano1
1Hosp Carlos III, Madrid, Spain and 2Inst de Salud Carlos III, Madrid, Spain |
685
 |
Screening for Hepatocellular Carcinoma in HIV/HCV Co-infected Patients: Impact on Staging, Therapy, and Survival Marina Nunez*1, L Kikuchi2, P Barreiro3, M Nelson4, M E Vispo3, E Page4, R Fox5, E Bini6, M Sherman7, N Bräu8, and Atlantic Liver Cancer in HIV Study Group
1Wake Forest Univ Sch of Med, Winston-Salem, NC, US; 2Univ of Sao Paulo, Brazil; 3Hosp Carlos III, Madrid, Spain; 4Chelsea and Westminster Hosp, London, UK; 5Univ of California, San Francisco, US; 6New York Univ Sch of Med, NY, US; 7Univ of Toronto, Canada; and 8Mt Sinai Sch of Med, New York, NY, US |
686
 |
In the HAART Era, in Viral Cirrhosis Liver Transplant Candidates, HIV Co-infection Remains as an Independent Predictor of Mortality on the Waiting List, but Not after Liver Transplantation A Moreno, R Bárcena, S del Campo, A Muriel, J Fortún, A Martinez, J Nuño, María Pérez-Elías*, J Casado, and S Moreno
Hosp Ramon y Cajal, Madrid, Spain |
687
 |
Short-term Plasma HIV-1 RNA Viral Load and Immunological Changes following Transitory Discontinuation of HAARTafter Liver Transplantation in HIV-1-infected Recipients Jose Miro*1, J González2, P Miralles3, M Montejo4, J Meneu5, A Rafecas6, M Tuset1, E Cordero7, I Perez1, A Rimola1, and GESIDA/FIPSE OLT in HIV-infected Patients Investigators
1Hosp Clin, Univ of Barcelona, Spain; 2Hosp Univ La Paz, Madrid, Spain; 3Hosp Gen Univ Gregorio Marañón, Madrid, Spain; 4Hosp Univ Cruces, Baracaldo, Spain; 5Hosp Univ 12 de Octubre, Madrid, Spain; 6Hosp Bellvitge, Univ of Barcelona, Spain; and 7Hosp Univ Virgen del Rocio, Sevilla, Spain |
688
 |
Outcomes in HIV/HCV Hemophilic vs Non-hemophilic Transplant Candidates Margaret Ragni*1, M DeVera1, M Roland2, M Wong3, V Stosor4, K Sherman5, D Hardy6, E Blumberg7, B Barin8, and P Stock2
1Univ of Pittsburgh, PA, US; 2Univ of California, San Francisco, US; 3Beth Israel Deaconess Med Ctr, Harvard Med Sch, Boston, MA, US; 4Northwestern Univ, Chicago, IL, US; 5Univ of Cincinnati, OH, US; 6Cedars-Sinai Med Ctr, Los Angeles, CA, US; 7Univ of Pennsylvania, Philadelphia, US; and 8EMMES Corp, Rockville, MD, US |
|